Jasper Therapeutics Stock Investor Sentiment

JSPRW Stock  USD 0.22  0.01  4.76%   
Slightly above 56% of all Jasper Therapeutics' sophisticated investors are looking to take a long position. The analysis of the overall investor sentiment regarding Jasper Therapeutics suggests that some traders are interested. Jasper Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Jasper Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
over six months ago at news.google.com         
Jasper Therapeutics Coverage Initiated by Analysts at HC Wainwright - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
TipRanks Perfect 10 List These 2 Top-Scoring Stocks Could Double , According to Analysts - Nasdaq
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Acquisition by Emster Kurt Von of 47000 shares of Jasper Therapeutics at 1.6 subject to Rule 16b-3
Macroaxis News
over six months ago at www.macroaxis.com         
Acquisition by Hoffen Howard I of 200000 shares of Jasper Therapeutics subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Analyzing Finch Therapeutics Group Jasper Therapeutics - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
DLA Piper advised the underwriters on a US50 million offering of common stock for Jasper Therapeutic...
Google News at Macroaxis
over six months ago at news.google.com         
Jasper Therapeutics Earns Outperform Rating from Analysts at Evercore ISI - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsw...
Google News at Macroaxis
over six months ago at news.google.com         
Can Jasper Therapeutics Inc Stock Rise to the Top of Healthcare Sector Monday - InvestorsObserver
Google News at Macroaxis
over six months ago at news.google.com         
Jasper Therapeutics Receives New Coverage from Analysts at Royal Bank of Canada - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
RBC starts Jasper Therapeutics at outperform, cites market opportunity - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Jasper Therapeutics Is a Great Choice for Trend Investors, Heres Why - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune Inflammatory Disease...
Google News at Macroaxis
over six months ago at news.google.com         
Jasper Therapeutics, Inc.s largest shareholders are retail investors with 42 percent ownership, inst...
Google News at Macroaxis
over six months ago at news.google.com         
Jasper Therapeutics Now Covered by Analysts at TD Cowen - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Jasper Therapeutics that are available to investors today. That information is available publicly through Jasper media outlets and privately through word of mouth or via Jasper internal channels. However, regardless of the origin, that massive amount of Jasper data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Jasper Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Jasper Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Jasper Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Jasper Therapeutics alpha.

Jasper Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of tradable shares by Mahal Jeetinder Singh of Jasper Therapeutics subject to Rule 16b-3
09/18/2024
2
Insider Trading
09/20/2024

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.